DEPOTSYSTEM ENTHALTEND GLATIRAMERAZETAT

European patent · EP2398488 · In force

Register entry

Publication number
EP2398488
Application number
EP10840699
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 19, 2010
Published
Dec 28, 2011
Granted
Nov 14, 2018
Protection ends at the latest
Aug 18, 2030
Next annual fee due
Aug 31, 2026
IPC classes
A61K 38/16 (2006.01)
A61K 9/16 (2006.01)
A61K 9/19 (2006.01)
A61K 9/50 (2006.01)
A61K 9/70 (2006.01)
A61K 38/10 (2006.01)
A61P 25/00 (2006.01)
Priority
US 291928 P 04.01.2010
PCT application
PCT/IL2010/000679 19.08.2010
PCT publication
WO2011/080733 07.07.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2025

    Change

    Published in Swissreg on 01.09.2025

  2. Sep 1, 2024

    Change

    Published in Swissreg on 01.09.2024

  3. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  4. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  5. Dec 21, 2018

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 21.12.2018

  6. Nov 14, 2018

    Granted

    Published in Swissreg on 14.11.2018

Parties

Holder

Mapi Pharma Limited

16 Einstein Street Weizmann Science Park P.O. Box 4113, 74140 Ness Ziona, IL

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

RUBNOV, Shai

65214 Tel Aviv, IL

MAROM, Ehud

44308 Kfar Saba, IL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.